Clinical trial
Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and…
NCT00410488 · M.D. Anderson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00410488 |
|---|---|
| Title | Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI) |
| Official title | Dose/Schedule Finding Study of Palonosetron in Sarcoma Patients Receiving Multi-Day Chemotherapy With Adriamycin and Ifosfamide (AI) |
| Lead sponsor | M.D. Anderson Cancer Center, Other |
| Collaborators | Eisai Inc. Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Sarcoma, Nausea, Vomiting |
| Intervention type | Drug |
| Interventions | Palonosetron - Single Dose, Palonosetron - Triple Dose, Adriamycin, Ifosfamide chemotherapy (AI), Zinecard, Mesna, Vincristine, Dexamethasone |
| Enrollment | 51 |
| Start date | Dec 1, 2006 |
| Primary completion | Jun 1, 2011 |
| Completion | Jun 1, 2011 |
| First posted | Dec 13, 2006 |
| Last update posted | Mar 22, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: